Pulse Oximeter Market Size, Scope, Demand, Applications and Opportunities Forecast, 2027

Share This Article

 Latest Study on “Pulse Oximeter Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2027”.

The global Pulse Oximeter market size is expected to be worth around US$ 5.1 Billion by 2027, according to a new report by Nova One Advisor .

The global Pulse Oximeter market size was valued at US$ 1.9 Billion in 2020 and is anticipated to grow at a CAGR of 9.6% during forecast period 2021 to 2027.

Get your Customized Research Report@ https://www.novaoneadvisor.com/report/customization/4407

Growth Factors:

Technological advancements in products, growing healthcare costs, and readmission, and increasing adoption of pulse oximetry devices are expected to boost market growth during the forecast period. Market players are introducing devices that are more efficient and support telehealth approaches. For instance, in February 2017, the company received a CE mark for Rad-97 Pulse CO-Oximeter used to monitor blood pressure at set intervals. It is also capable of transferring the data to a remotely connected device.

There are various other types of oximeters such as wrist-worn oximeters, bedside, or desktop oximeters, and mobile phone pulse oximeters, the latest addition. These oximetry devices are equipped with a sensor that is compatible with the software installed in a user’s mobile phone, which analyzes data to display information. For instance, iHealth Labs, a subsidiary of a China-based company, Andon Health, offers such products. In October 2013, the company received FDA approval for its wireless pulse oximetry device.

Pulse Oximeter Market Dynamics
Driver: 
Chronic obstructive pulmonary disease (COPD), asthma, and pneumonia are among the most prevalent respiratory diseases worldwide. In COPD, asthma, and pneumonia, the airways of the lungs are obstructed, making it difficult to move air in and out of the lungs that eventually leads to the low oxygen concentration in the blood. In the coming years, the prevalence of COPD is expected to increase due to rising tobacco consumption and the growing geriatric population (Source: WHO). According to the AIHW, the prevalence of COPD increases with age, mostly occurring in people aged 45 and over. According to the global initiative for chronic obstructive lung disease (GOLD 2019 report), 65 million people suffer from COPD and 3 million die from it each year, making it the third-leading cause of death worldwide. Regular monitoring of blood oxygen levels may reduce the mortality rate of patients with COPD. Also, COVID-19 is also directly linked to acute respiratory distress syndrome (ARDS) and pneumonia. The virus directly impacts the lungs and damages the walls and linings of the capillaries and alveolus, causing heavy breathing, dry cough, increased heart rate, and breathing difficulties. According to Worldometer, the virus has affected over 160 million people globally as of May 2021 and resulted in 3,346,760 deaths. The outbreak has led to concerns over timely medical attention, leading to an increased demand for pulse oximeters in healthcare facilities, home care, and for remote management of COVID-19 positive patients as an early detection tool to reduce further complications.

As a result, the growth in the number of patients suffering from respiratory diseases such as COPD, asthma, pneumonia, and infections disease such as COVID -19 will drive the demand for pulse oximeters in the coming years.

Restraint: 
Medical products that are approved to be sold directly to the consumers without prescription from relevant medical authorities are referred to as OTC medical products. OTC pulse oximeters do not need FDA clearance and can be bought directly from any pharmacy without a prescription. However, there are concerns regarding the safety and accuracy of pulse oximeters bought over the counter. The PAHO guidelines also recommend that while pulse oximetry can be a useful resource in clinical decision-making, it is not a substitute for clinical evaluation and is not in itself sufficient for diagnosis. With the increasing need for efficient detection, monitoring, and treatment of COVID-19 patients, along with the need to curb the further spread of the pandemic, the US Food and Drug Administration (FDA) has released an advisory for patients and healthcare providers that although pulse oximetry is useful for estimating blood oxygen levels, pulse oximeters have limitations and risk of inaccuracy under certain circumstances. This may hamper the growth of the market to a certain extent.

Opportunity :
In recent years, the rising healthcare expenditure, especially in hospital settings, has shifted the focus towards alternative methods of treatment, such as home healthcare. This, in turn, has ensured a growing demand for effective home-use devices such as pulse oximeters. The major factors driving the demand for home healthcare include the rapidly growing global geriatric population, changing epidemiology, and the availability of cost-effective home care devices and services as compared to hospital-based care. The delivery of quality care in non-hospital settings has resulted in better patient compliance, proactive treatments, improved patient satisfaction, and improved care quality. The necessity to frequently monitor the blood oxygen saturation of patients tested with COVID-19 has also increased the demand for pulse oximeters in home healthcare settings, as it allows patients to share their vital sign parameters such as SpO2 and temperature with their treating physician using teleconsultation. The advent of technological innovation in fingertip and handheld pulse oximeters enables easy storage and transfer of patient data to the care provider. Handheld pulse oximeters are easy-to-use self-monitoring devices that enable the user to share data with healthcare providers from the comfort of their home using either telemedicine services or real-time health monitoring services. The adoption of handheld pulse oximeters is higher among the elderly population as they prefer home care over inpatient care, owing to ease of convenience and reduced healthcare costs.

Highlights of the Report:

  • The fingertip pulse oximetry devices are being used by customers to self-monitor symptoms of COVID-19 contributing to segment growth since the onset of the pandemic
  • In handheld pulse oximetry devices, the probe, which is very delicate and prone to damage, can be replaced, unlike in fingertip oximeters, and is expected to be in high demand due to the advantage of reduced risk of COVID-19 transmission
  • There is an upward trend in the use of the medical device in homecare settings as it enables tracking and storing of patient’s oxygen level readings, which reduces the need for hospital readmissions
  • North America held the largest share in the market in 2020 due to factors such as availability of funds for R&D. The sales for fingertip pulse oximetry devices soared in January 2020 and March 2020 in the U.S. post the country-wide spread of the novel coronavirus and release of the WHO guidelines citing the oximeter as an essential device for monitoring blood oxygen during self-management
  • In Asia Pacific, the demand for medical devices has increased from hospitals for monitoring critically ill COVID-19 patients. As the spread of the novel coronavirus has progressed significantly, the Ministry of Health and Family Welfare in India has notified all healthcare facilities to make necessary arrangements for devices used in diagnostics, treatment, and management of Severe Acute Respiratory Syndrome (SARS)
  • The industry is also witnessing mergers, acquisitions, and licensing agreements. For instance, in December 2016, Nihon Kohden announced an absorption-type merger of 11 wholly-owned consolidated subsidiaries to improve management and efficiency of operations

Download This Full Research Report, Click Here@ https://www.novaoneadvisor.com/report/checkout/4407

Recent report on the Pulse Oximeter market, with the help of a comprehensive outlook, provides readers with an assessment of the global market landscape. This study on the Pulse Oximeter market analyzes the scenario for the period of 2017 to 2027, wherein, 2021 is the base year and 2020 is historical data. This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global Pulse Oximeter market for the forecast period of 2021–2027. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.

The report analyzes the historical and present-day scenario of the global Pulse Oximeter market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the Pulse Oximeter market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the market.

The report delves into the competition landscape of the global Pulse Oximeter market. Key players operating in the market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the Pulse Oximeter market that are profiled in this report.

Y-o-Y growth comparison, volume and revenue comparison, and market share comparison of various market segments are provided in the report. The Pulse Oximeter market is analyzed at both regional and country levels.

Pulse Oximeter Market top Key Players:

Medtronic plc (Ireland), Masimo Corporation(US), Koninklijke Philips N.V. (Netherlands), Nonin Medical Inc. (US), Meditech Equipment Co., Ltd. (China), Contec Medical Systems Co., Ltd. (China), GE Healthcare (US), ChoiceMMed (China), OSI Systems, Inc. (US), Nihon Kohden Corporation (Japan), Smiths Group plc (UK), Honeywell International Inc. (US), Dr Trust (US), HUM Gesellschaft für Homecare und Medizintechnik mbH (Germany), Beurer GmbH (Germany), The Spengler Holtex Group (France), Shanghai Berry Electronic Technology Co., Ltd. (China), Promed Group Co., Ltd. (China), Tenko Medical System Corp. (US), and Shenzhen Aeon Technology Co., Ltd. (China).

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

Global Pulse Oximeter Market, by Product

  • Equipment
  • Sensors
    • Reusable sensors
    • Disposable sensors

Global Pulse Oximeter Market, by Type

  • Portable pulse oximeters
    • Handhelp pulse oximeter
    • Fingertip pulse oximeter
    • Wearable pulse oximeter
  • Bedside/ Table top pulse oximeters

Global Pulse Oximeter Market, by Technology

  • Conventional Devices
  • Connected Devices

Global Pulse Oximeter Market, by Age group

  • Adult
  • Pediatric
    • Neonatal
    • Infant/ children

Global Pulse Oximeter Market, by End User

  • Hospitals
  • Home Care settings
    • Prescription Home use
    • OTC Home use
  • Ambulatory Care settings

Research Methodology

A unique research methodology has been utilized to conduct a comprehensive research on the growth of the global Pulse Oximeter market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.

These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global Pulse Oximeter market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.

Key Questions are

  • What are the key factors influencing the Pulse Oximeter market in each region?
  • How much value will the global market generate by the end of the forecast period?
  • What will be the CAGR of the global market between 2021 and 2027?
  • What would be the Y-o-Y growth trend of the global market between 2021 and 2027?
  • What is the future scope and current trends in technologies of the global market?
  • What is the revenue of the global market based on segments?
  • Which key strategies are used by top players of the global market?
  • Which are the leading companies in the global market?
  • What are the essential strategies by key stakeholders in the market to expand their geographic presence?
  • What are the major advancements witnessed in the global market?

 Why Buy this Report?

The purpose of Nova one advisor’s Pulse Oximeter market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

TABLE OF CONTENT

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Pulse Oximeter Market, By Product

7.1.  Pulse Oximeter Market, by Product, 2021-2027

7.1.1.     Equipment

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Sensors

7.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Pulse Oximeter Market, By Type

8.1.  Pulse Oximeter Market, by Type, 2021-2027

8.1.1.     Portable pulse oximeters

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Portable pulse oximeters

8.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Pulse Oximeter Market, By Technology

9.1.  Pulse Oximeter Market, by Technology, 2021-2027

9.1.1.     Portable pulse oximeters

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Connected Devices

9.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Pulse Oximeter  Market, By Age group

10.1.          Pulse Oximeter Market, by Age group, 2021-2027

10.1.1.  Adult

10.1.1.1.       Market Revenue and Forecast (2016-2027)

10.1.2.  Pediatric

10.1.2.1.       Market Revenue and Forecast (2016-2027)

Chapter 11.Global Pulse Oximeter  Market, By End User

11.1.          Pulse Oximeter Market, by End User, 2021-2027

11.1.1.  Hospitals

11.1.1.1.       Market Revenue and Forecast (2016-2027)

11.1.2.  Home Care settings

11.1.2.1.       Market Revenue and Forecast (2016-2027)

Chapter 12.Global Pulse Oximeter Market, Regional Estimates and Trend Forecast

12.1.          North America

12.1.1.  Market Revenue and Forecast, by Product (2016-2027)

12.1.2.  Market Revenue and Forecast, by Type (2016-2027)

12.1.3.  Market Revenue and Forecast, by Technology (2016-2027)

12.1.4.  Market Revenue and Forecast, by Age group (2016-2027)

12.1.5.  Market Revenue and Forecast, by End User (2016-2027)

12.1.6.  U.S.

12.1.6.1.       Market Revenue and Forecast, by Product (2016-2027)

12.1.6.2.       Market Revenue and Forecast, by Type (2016-2027)

12.1.6.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.1.6.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.1.6.5.       Market Revenue and Forecast, by End User (2016-2027)

12.1.7.  Rest of North America

12.1.7.1.       Market Revenue and Forecast, by Product (2016-2027)

12.1.7.2.       Market Revenue and Forecast, by Type (2016-2027)

12.1.7.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.1.7.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.1.7.5.       Market Revenue and Forecast, by End User (2016-2027)

12.2.          Europe

12.2.1.  Market Revenue and Forecast, by Product (2016-2027)

12.2.2.  Market Revenue and Forecast, by Type (2016-2027)

12.2.3.  Market Revenue and Forecast, by Technology (2016-2027)

12.2.4.  Market Revenue and Forecast, by Age group (2016-2027)

12.2.5.  Market Revenue and Forecast, by End User (2016-2027)

12.2.6.  UK

12.2.6.1.       Market Revenue and Forecast, by Product (2016-2027)

12.2.6.2.       Market Revenue and Forecast, by Type (2016-2027)

12.2.6.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.2.6.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.2.6.5.       Market Revenue and Forecast, by End User (2016-2027)

12.2.7.  Germany

12.2.7.1.       Market Revenue and Forecast, by Product (2016-2027)

12.2.7.2.       Market Revenue and Forecast, by Type (2016-2027)

12.2.7.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.2.7.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.2.7.5.       Market Revenue and Forecast, by End User (2016-2027)

12.2.8.  France

12.2.8.1.       Market Revenue and Forecast, by Product (2016-2027)

12.2.8.2.       Market Revenue and Forecast, by Type (2016-2027)

12.2.8.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.2.8.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.2.8.5.       Market Revenue and Forecast, by End User (2016-2027)

12.2.9.  Rest of Europe

12.2.9.1.       Market Revenue and Forecast, by Product (2016-2027)

12.2.9.2.       Market Revenue and Forecast, by Type (2016-2027)

12.2.9.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.2.9.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.2.9.5.       Market Revenue and Forecast, by End User (2016-2027)

12.3.          APAC

12.3.1.  Market Revenue and Forecast, by Product (2016-2027)

12.3.2.  Market Revenue and Forecast, by Type (2016-2027)

12.3.3.  Market Revenue and Forecast, by Technology (2016-2027)

12.3.4.  Market Revenue and Forecast, by Age group (2016-2027)

12.3.5.  Market Revenue and Forecast, by End User (2016-2027)

12.3.6.  India

12.3.6.1.       Market Revenue and Forecast, by Product (2016-2027)

12.3.6.2.       Market Revenue and Forecast, by Type (2016-2027)

12.3.6.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.3.6.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.3.6.5.       Market Revenue and Forecast, by End User (2016-2027)

12.3.7.  China

12.3.7.1.       Market Revenue and Forecast, by Product (2016-2027)

12.3.7.2.       Market Revenue and Forecast, by Type (2016-2027)

12.3.7.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.3.7.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.3.7.5.       Market Revenue and Forecast, by End User (2016-2027)

12.3.8.  Japan

12.3.8.1.       Market Revenue and Forecast, by Product (2016-2027)

12.3.8.2.       Market Revenue and Forecast, by Type (2016-2027)

12.3.8.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.3.8.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.3.8.5.       Market Revenue and Forecast, by End User (2016-2027)

12.3.9.  Rest of APAC

12.3.9.1.       Market Revenue and Forecast, by Product (2016-2027)

12.3.9.2.       Market Revenue and Forecast, by Type (2016-2027)

12.3.9.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.3.9.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.3.9.5.       Market Revenue and Forecast, by End User (2016-2027)

12.4.          MEA

12.4.1.  Market Revenue and Forecast, by Product (2016-2027)

12.4.2.  Market Revenue and Forecast, by Type (2016-2027)

12.4.3.  Market Revenue and Forecast, by Technology (2016-2027)

12.4.4.  Market Revenue and Forecast, by Age group (2016-2027)

12.4.5.  Market Revenue and Forecast, by End User (2016-2027)

12.4.6.  GCC

12.4.6.1.       Market Revenue and Forecast, by Product (2016-2027)

12.4.6.2.       Market Revenue and Forecast, by Type (2016-2027)

12.4.6.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.4.6.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.4.6.5.       Market Revenue and Forecast, by End User (2016-2027)

12.4.7.  North Africa

12.4.7.1.       Market Revenue and Forecast, by Product (2016-2027)

12.4.7.2.       Market Revenue and Forecast, by Type (2016-2027)

12.4.7.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.4.7.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.4.7.5.       Market Revenue and Forecast, by End User (2016-2027)

12.4.8.  South Africa

12.4.8.1.       Market Revenue and Forecast, by Product (2016-2027)

12.4.8.2.       Market Revenue and Forecast, by Type (2016-2027)

12.4.8.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.4.8.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.4.8.5.       Market Revenue and Forecast, by End User (2016-2027)

12.4.9.  Rest of MEA

12.4.9.1.       Market Revenue and Forecast, by Product (2016-2027)

12.4.9.2.       Market Revenue and Forecast, by Type (2016-2027)

12.4.9.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.4.9.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.4.9.5.       Market Revenue and Forecast, by End User (2016-2027)

12.5.          Latin America

12.5.1.  Market Revenue and Forecast, by Product (2016-2027)

12.5.2.  Market Revenue and Forecast, by Type (2016-2027)

12.5.3.  Market Revenue and Forecast, by Technology (2016-2027)

12.5.4.  Market Revenue and Forecast, by Age group (2016-2027)

12.5.5.  Market Revenue and Forecast, by End User (2016-2027)

12.5.6.  Brazil

12.5.6.1.       Market Revenue and Forecast, by Product (2016-2027)

12.5.6.2.       Market Revenue and Forecast, by Type (2016-2027)

12.5.6.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.5.6.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.5.6.5.       Market Revenue and Forecast, by End User (2016-2027)

12.5.7.  Rest of LATAM

12.5.7.1.       Market Revenue and Forecast, by Product (2016-2027)

12.5.7.2.       Market Revenue and Forecast, by Type (2016-2027)

12.5.7.3.       Market Revenue and Forecast, by Technology (2016-2027)

12.5.7.4.       Market Revenue and Forecast, by Age group (2016-2027)

12.5.7.5.       Market Revenue and Forecast, by End User (2016-2027)

Chapter 13.   Company Profiles

13.1.                 Medtronic plc (Ireland)

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.                 Masimo Corporation(US)

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.                 Koninklijke Philips N.V. (Netherlands)

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.                 Nonin Medical Inc. (US)

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.                 Meditech Equipment Co., Ltd. (China)

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.                 Contec Medical Systems Co., Ltd. (China)

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.                 GE Healthcare (US)

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.                 ChoiceMMed (China)

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.                 OSI Systems, Inc. (US)

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.              Nihon Kohden Corporation (Japan)

13.10.1.                   Company Overview

13.10.2.                   Product Offerings

13.10.3.                   Financial Performance

13.10.4.                   Recent Initiatives

13.11.              Smiths Group plc (UK)

13.11.1.                   Company Overview

13.11.2.                   Product Offerings

13.11.3.                   Financial Performance

13.11.4.                   Recent Initiatives

13.12.              Honeywell International Inc. (US)

13.12.1.                   Company Overview

13.12.2.                   Product Offerings

13.12.3.                   Financial Performance

13.12.4.                   Recent Initiatives

13.13.              Dr Trust (US)

13.13.1.                   Company Overview

13.13.2.                   Product Offerings

13.13.3.                   Financial Performance

13.13.4.                   Recent Initiatives

13.14.              HUM Gesellschaft für Homecare und Medizintechnik mbH (Germany)

13.14.1.                   Company Overview

13.14.2.                   Product Offerings

13.14.3.                   Financial Performance

13.14.4.                   Recent Initiatives

13.15.              Beurer GmbH (Germany)

13.15.1.                   Company Overview

13.15.2.                   Product Offerings

13.15.3.                   Financial Performance

13.15.4.                   Recent Initiatives

13.16.              The Spengler Holtex Group (France)

13.16.1.                   Company Overview

13.16.2.                   Product Offerings

13.16.3.                   Financial Performance

13.16.4.                   Recent Initiatives

13.17.              Shanghai Berry Electronic Technology Co., Ltd. (China)

13.17.1.                   Company Overview

13.17.2.                   Product Offerings

13.17.3.                   Financial Performance

13.17.4.                   Recent Initiatives

13.18.              Promed Group Co., Ltd. (China)

13.18.1.                   Company Overview

13.18.2.                   Product Offerings

13.18.3.                   Financial Performance

13.18.4.                   Recent Initiatives

13.19.              Tenko Medical System Corp. (US)

13.19.1.                   Company Overview

13.19.2.                   Product Offerings

13.19.3.                   Financial Performance

13.19.4.                   Recent Initiatives

13.20.              henzhen Aeon Technology Co., Ltd. (China)

13.20.1.                   Company Overview

13.20.2.                   Product Offerings

13.20.3.                   Financial Performance

13.20.4.                   Recent Initiatives

Chapter 14.   Research Methodology

14.1.                 Primary Research

14.2.                 Secondary Research

14.3.                 Assumptions

Chapter 15.   Appendix

15.1.                 About Us

15.2.                 Glossary of Terms

You Can Purchase Complete Report@ https://www.novaoneadvisor.com/report/checkout/4407

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@novaoneadvisor.com

Web: https://www.novaoneadvisor.com/

James Root

James Root have over 6+ years of experience working in business development, and customer retention. I’ve gained my experience through serving higher education, healthcare, automotive, aerospace, manufacturing, local government and hospitality businesses with technical solutions.

View all posts by James Root →